Taysha Gene Therapies Inc (TSHA) — Free Cash Flow Generation Index
Taysha Gene Therapies Inc (TSHA) has a Free Cash Flow Generation Index of 0.84x as of December 2022. Free cash flow of $11.97 Million represents 1% of operating cash flow ($14.28 Million). Explore TSHA capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Taysha Gene Therapies Inc Free Cash Flow Generation Index (2019–2019)
Historical FCF Generation Index trend for Taysha Gene Therapies Inc across 1 annual periods. For the full cash flow conversion analysis, see TSHA operating cash flow.
Annual Free Cash Flow Generation for Taysha Gene Therapies Inc (2019–2019)
Year-by-year Free Cash Flow Generation Index for Taysha Gene Therapies Inc. Check how aggressively does Taysha Gene Therapies Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | 1.00x | $135.00K | $135.00K | $82.00K | — |